A preliminary lymphocyte subset analysis by flow cytometry that includes markers for B lymphocytes (CD19), T lymphocytes (CD3), and natural killer cells (CD56/16) is the first-line investigation for SCID, and it helps in identifying the subtypes of SCID (7–13) (Table 1, Supplementary Figure 1A). Here, CD19 is linked to severe combined immunodeficiency.